LEE PHAN: Open Payments
NPI 1790458552 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,473 in 153 payments from 20 companies in 2025. Trend: 2023 $143 · 2024 $1,552 · 2025 $5,473
Food & beverage: $5,271Education: $201
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 27 | $1,070 |
| UCB, Inc. | 22 | $1,014 |
| ABBVIE INC. | 22 | $735 |
| Janssen Biotech, Inc. | 14 | $726 |
| GENZYME CORPORATION | 6 | $438 |
| LEO Pharma Inc. | 10 | $312 |
| Arcutis Biotherapeutics, Inc. | 12 | $250 |
| Regeneron Healthcare Solutions, Inc. | 7 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $199 |
| Amgen Inc. | 5 | $149 |
Products named: Bimzelx, NEMLUVIO, TREMFYA, SKYRIZI, DUPIXENT, AKLIEF, Zoryve, ANZUPGO.
Industry payments across NV — which companies pay providers there.
